Corvus Pharmaceuticals Inc (FRA:C17) Stock News, Headlines & Updates
Corvus Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 25, 2025
Corvus Pharmaceuticals (CRVS) Gains China Approval for Soquelitinib Trial | CRVS Stock News
GuruFocus News • 7:16am
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
Marketwired • 7:00am
Jun 11, 2025
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress | CRVS Stock News
GuruFocus News • 6:22am
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress
Marketwired • 6:00am
Jun 04, 2025
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis | CRVS Stock News
GuruFocus News • 6:19am
Corvus Pharmaceuticals (CRVS) Reports Promising Results for Atopic Dermatitis Treatment | CRVS Stock News
GuruFocus News • 6:18am
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Marketwired • 6:00am
May 28, 2025
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
Marketwired • 4:00pm
May 20, 2025
CRVS: Mizuho Adjusts Price Target for Corvus Pharma | CRVS Stock News
GuruFocus News • 9:30am
Corvus Pharmaceuticals (CRVS) Target Price Adjusted Amid Positive Drug Data | CRVS Stock News
GuruFocus News • 7:19am
May 12, 2025
Corvus Pharmaceuticals (CRVS) Sees Increased Investor Interest Amid Clinical Updates | CRVS Stock News
GuruFocus News • 11:16am
Corvus Pharmaceuticals (CRVS) Sees Notable Increase in Borrow Rate | CRVS Stock News
GuruFocus News • 8:19am
May 09, 2025
CRVS: Oppenheimer Raises Price Target for Corvus Pharma | CRVS Stock News
GuruFocus News • 1:00pm
Oppenheimer Ups Price Target for Corvus Pharmaceuticals (CRVS) Amid Positive Data | CRVS Stock News
GuruFocus News • 8:32am
Corvus Pharmaceuticals Inc (CRVS) Q1 2025 Earnings Call Highlights: A Turnaround with Promising Trial Results and Financial Stability
GuruFocus News • 1:41am
Q1 2025 Corvus Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:21pm
May 08, 2025
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results
Marketwired • 4:00pm
Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Marketwired • 4:00pm
Corvus Pharmaceuticals (CRVS) Advances Soquelitinib in Dermatology and Oncology Trials | CRVS Stock News
GuruFocus News • 3:59pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news